A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia (Q33360707)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia |
scientific article |
Statements
1 reference
A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia (English)
1 reference
Hagop Kantarjian
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
Srdan Verstovsek
1 reference
Jorge Cortes
1 reference
Francis Giles
1 reference
Guillermo Garcia-Manero
1 reference
Michael Andreeff
1 reference
Mario Sznol
1 reference
Sima Jeha
1 reference
Deborah Thomas
1 reference
Miloslav Beran
1 reference
Charles Koller
1 reference
Ann Cahill
1 reference
Caroline Clairmont
1 reference
1 May 2004
1 reference
1 reference
10
1 reference
2908-2917
1 reference
Identifiers
1 reference
1 reference